Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ji Geng, Xiao Yuan, Mingzhen Wei, Junchao Wu & Zheng-Hong Qin. (2018) The diverse role of TIGAR in cellular homeostasis and cancer. Free Radical Research 52:11-12, pages 1240-1249.
Read now
Read now
Ningxia Xie, Polina Vikhreva, Margherita Annicchiarico-Petruzzelli, Ivano Amelio, Nicolai Barlev, Richard A. Knight & Gerry Melino. (2018) Integrin-β4 is a novel transcriptional target of TAp73. Cell Cycle 17:5, pages 589-594.
Read now
Read now
Subhasree Basu & Maureen E. Murphy. (2016) p53 family members regulate cancer stem cells. Cell Cycle 15:11, pages 1403-1404.
Read now
Read now
Articles from other publishers (26)
Xu Chen, Qihang Yuan, Hewen Guan, Xueying Shi, Jiaao Sun, Zhiqiang Wu, Jie Ren, Shilin Xia & Dong Shang. (2023) Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. Frontiers in Oncology 13.
Crossref
Crossref
Austin J. Taylor, Evgeniy Panzhinskiy, Paul C. Orban, Francis C. Lynn, David F. Schaeffer, James D. Johnson, Janel L. Kopp & C. Bruce Verchere. (2023) Islet amyloid polypeptide does not suppress pancreatic cancer. Molecular Metabolism 68, pages 101667.
Crossref
Crossref
Shinjinee Sengupta, Shaikh Maryam Ghufran, Aqsa Khan, Subhrajit Biswas & Susanta Roychoudhury. (2022) Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness. Cancer Cell International 22:1.
Crossref
Crossref
Yuanzheng Yang, Zhanglong Peng, Elsa R. Flores & Eugenie S. Kleinerman. (2022) Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming. Cancers 14:17, pages 4310.
Crossref
Crossref
Zuzana Pokorna, Vaclav Hrabal, Vlastimil Tichy, Borivoj Vojtesek & Philip J. Coates. (2022) DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Jaya Pratap Pinnamaneni, Vivek P. Singh, Mary B. Kim, Christopher T. Ryan, Aarthi Pugazenthi, Deepthi Sanagasetti, Megumi Mathison, Jianchang Yang & Todd K. Rosengart. (2022) p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. Scientific Reports 12:1.
Crossref
Crossref
Marco Napoli, Sarah J. Wu, Bethanie L. Gore, Hussein A. Abbas, Kyubum Lee, Rahul Checker, Shilpa Dhar, Kimal Rajapakshe, Aik Choon Tan, Min Gyu Lee, Cristian Coarfa & Elsa R. Flores. (2022) ΔNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer. Nature Communications 13:1.
Crossref
Crossref
Fucai Li, Zhixue Du, Xiangyi Huang, Chaoqing Dong & Jicun Ren. (2021) Analyses of p73 Protein Oligomerization and p73–MDM2 Interaction in Single Living Cells Using In Situ Single Molecule Spectroscopy. Analytical Chemistry 93:2, pages 886-894.
Crossref
Crossref
Xiangxuan Zhao, Wei Sun, Ying Ren & Zaiming Lu. (2021) Therapeutic potential of p53 reactivation in cervical cancer. Critical Reviews in Oncology/Hematology 157, pages 103182.
Crossref
Crossref
Chenxi Xu, Jianjian Zhuang & Xiaobo Zhang. (2020) 2-[(4-Hydroxybenzyl) Amino] Phenol (HBAP) Restores the Mutated p53 to the Level Similar to That of Wild-Type p53 Protein and Inhibits Breast Cancer Growth in vivo to by Inducing Tumor Cells Apoptosis. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Albert B. DeLeo & Ettore Appella. (2020) The p53 Saga: Early Steps in the Development of Tumor Immunotherapy. The Journal of Immunology 204:9, pages 2321-2328.
Crossref
Crossref
Mohammed Amjed Alsaegh, Alaa Muayad Altaie & Shengrong Zhu. (2019) p63 Expression and its Relation to Epithelial Cells Proliferation in Dentigerous Cyst, Odontogenic Keratocyst, and Ameloblastoma. Pathology & Oncology Research 26:2, pages 1175-1182.
Crossref
Crossref
Jinhong Meng, Aristides D. Tagalakis & Stephen L. Hart. (2020) Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells. Scientific Reports 10:1.
Crossref
Crossref
Anna Ostrovskaya, Caroline Hick, Dana S. Hutchinson, Brett W. Stringer, Peter J. Wookey, Denise Wootten, Patrick M. Sexton & Sebastian G. B. Furness. (2019) Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas. BMC Cancer 19:1.
Crossref
Crossref
Alicja Sznarkowska, Anna Kostecka, Anna Kawiak, Pilar Acedo, Mattia Lion, Alberto Inga & Joanna Zawacka-Pankau. (2018) Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells. Cell Division 13:1.
Crossref
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Crossref
Hui Zou, Runying Zou, Keke Chen, Chengguang Zhu, Xin Tian, Yalan You & Xiangling He. (2018) miR‐129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63‐dependent manner. Journal of Cellular Biochemistry 119:11, pages 9217-9228.
Crossref
Crossref
Aiping Fang, Shijie Zhou, Xiaolan Su, Chuang Liu, Xiaoxin Chen, Yang Wan, Xiaohong Lei, Linshen Xie, Yiping Jia, Wenzhi Wang, Luo Yang, Xuejiao Song & Yuqin Yao. (2018)
RAMP3
is a prognostic indicator of liver cancer and might reduce the adverse effect of
TP53
mutation on survival
. Future Oncology 14:25, pages 2615-2625.
Crossref
Crossref
Vivekkumar Patel, Vivek P. Singh, Jaya Pratap Pinnamaneni, Deepthi Sanagasetti, Jacqueline Olive, Megumi Mathison, Austin Cooney, Elsa R. Flores, Ronald G. Crystal, Jianchang Yang & Todd K. Rosengart. (2018) p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells. The Journal of Thoracic and Cardiovascular Surgery 156:2, pages 556-565.e1.
Crossref
Crossref
Yoko Itahana & Koji Itahana. (2018) Emerging Roles of p53 Family Members in Glucose Metabolism. International Journal of Molecular Sciences 19:3, pages 776.
Crossref
Crossref
Brigitte M. Pützer, Manish Solanki & Ottmar Herchenröder. (2017) Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 120, pages 89-107.
Crossref
Crossref
Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, Cristina Ivan, Cristian Rodriguez-Aguayo, Enrique Fuentes-Mattei, Lianchun Xiao, Ivan Vannini, Roxana S. Redis, Lucilla D'Abundo, Xinna Zhang, Milena S. Nicoloso, Simona Rossi, Vianey Gonzalez-Villasana, Rajesha Rupaimoole, Manuela Ferracin, Fortunato Morabito, Antonino Neri, Peter P. Ruvolo, Vivian R. Ruvolo, Chad V. Pecot, Dino Amadori, Lynne Abruzzo, Steliana Calin, Xuemei Wang, M. James You, Alessandra Ferrajoli, Robert Orlowski, William Plunkett, Tara M. Lichtenberg, Ramana V. Davuluri, Ioana Berindan-Neagoe, Massimo Negrini, Ignacio I. Wistuba, Hagop M. Kantarjian, Anil K. Sood, Gabriel Lopez-Berestein, Michael J. Keating, Muller Fabbri & George A. Calin. (2017) Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clinical Cancer Research 23:11, pages 2891-2904.
Crossref
Crossref
Marco Napoli & Elsa R Flores. (2016) The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy. British Journal of Cancer 116:2, pages 149-155.
Crossref
Crossref
Elsa R. Flores. (2016) Commentary on “Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents”. Cancer Research 76:23, pages 6763-6764.
Crossref
Crossref
SGB Furness, DL Hare, A Kourakis, AM Turnley & PJ Wookey. (2016) A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death. Cell Death Discovery 2:1.
Crossref
Crossref
Nianshuang Li, Chuan Xie & Nong-Hua Lu. (2016)
p53, a potential predictor of
Helicobacter pylori
infection-associated gastric carcinogenesis?
. Oncotarget 7:40, pages 66276-66286.
Crossref
Crossref